Free Trial
NASDAQ:AHCO

AdaptHealth Q2 2025 Earnings Report

AdaptHealth logo
$9.22 -0.23 (-2.43%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$9.72 +0.50 (+5.48%)
As of 07/11/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AdaptHealth EPS Results

Actual EPS
N/A
Consensus EPS
$0.15
Beat/Miss
N/A
One Year Ago EPS
N/A

AdaptHealth Revenue Results

Actual Revenue
N/A
Expected Revenue
$804.97 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

AdaptHealth Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 5, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

AdaptHealth Earnings Headlines

AdaptHealth Completes Sale of Infusion Assets
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More AdaptHealth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AdaptHealth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AdaptHealth and other key companies, straight to your email.

About AdaptHealth

AdaptHealth (NASDAQ:AHCO) (NASDAQ: AHCO) is a leading provider of home medical equipment (HME) and related services in the United States. The company offers a comprehensive portfolio of products designed to support patients with chronic and acute health conditions in the comfort of their own homes. Its core offerings include oxygen therapy, sleep apnea devices, mobility solutions such as wheelchairs and scooters, respiratory care equipment and home infusion therapy. AdaptHealth’s integrated model combines product distribution, clinical support and patient education to enhance treatment adherence and outcomes.

Founded through the consolidation of several regional HME providers, AdaptHealth went public in late 2020 and has since grown through strategic acquisitions of established businesses. These acquisitions have expanded its service footprint and enriched its product mix, enabling AdaptHealth to serve patients with a broad spectrum of medical needs. The company operates a nationwide network of distribution and fulfillment centers, supported by a field staff of respiratory therapists, nurses and patient care coordinators who provide hands-on support and remote monitoring capabilities.

AdaptHealth’s history reflects a series of targeted integrations aimed at strengthening its market position. Key transactions include the acquisition of Rotech Healthcare and Apria Healthcare’s home infusion division, which together extended the company’s reach into new geographic markets and added specialized clinical services. Operational investments in technology platforms for order management, telehealth and remote patient monitoring further differentiate AdaptHealth’s offering by streamlining logistics and enhancing communication between caregivers and clinicians.

The company is led by a management team of seasoned healthcare executives with decades of experience in medical device distribution, clinical services and supply chain operations. Under the guidance of its Chief Executive Officer, AdaptHealth continues to pursue organic growth and bolt-on acquisitions while maintaining a focus on service quality and regulatory compliance. Its board of directors includes industry veterans in healthcare management, medical technology and financial oversight, all working to support AdaptHealth’s mission of enabling better patient outcomes at home.

View AdaptHealth Profile

More Earnings Resources from MarketBeat